Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Munir Alam

Showing results (151-160 of 206) with videos related to

Pageof 21
Sort By:
Nature Structural & Molecular Biology|May 28, 2013
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16Marie Pancera, Syed Shahzad-Ul-Hussan, Nicole A Doria-Rose, et al.
Journal of Virology|May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesM Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
Plos Pathogens|December 3, 2019
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Cell Host & Microbe|September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesThomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.
Journal of Virology|November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and PotencyDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Journal of Virology|April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostSandrine L Hulot, Bette Korber, Elena E Giorgi, et al.
Science Immunology|August 11, 2022
An antibody from single human V<sub>H</sub>-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusionSai Luo, Jun Zhang, Alex J B Kreutzberger, et al.
Pageof 21

Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Nature Structural & Molecular Biology|May 28, 2013
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16Marie Pancera, Syed Shahzad-Ul-Hussan, Nicole A Doria-Rose, et al.
Journal of Virology|May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesM Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Journal of Virology|January 12, 2018
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and PhagocytosisSaintedym Wills, Kwan-Ki Hwang, Pinghuang Liu, et al.
Plos Pathogens|December 3, 2019
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodiesCelia C LaBranche, Rory Henderson, Allen Hsu, et al.
Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.
Cell Host & Microbe|September 12, 2014
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodiesThomas B Kepler, Hua-Xin Liao, S Munir Alam, et al.
Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.
Journal of Virology|November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and PotencyDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Journal of Virology|April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostSandrine L Hulot, Bette Korber, Elena E Giorgi, et al.
Science Immunology|August 11, 2022
An antibody from single human V<sub>H</sub>-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusionSai Luo, Jun Zhang, Alex J B Kreutzberger, et al.
Pageof 21